IP Library Granted Patent US 8,057,379
Granted Patent B2
US 8,057,379 · App. 12/012,744 · Granted Nov 15, 2011

Treatment of a body cavity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,057,379
App. No.
12/012,744
Granted
Nov 15, 2011
Kind
B2
Abstract

Devices and methods are provided for controlled application of a treatment to tissue adjacent a body cavity, such as after removal of tissue, e.g. cancer. A device embodying features of the invention includes one or more radiation shielding components to control emitted radiation from a radiation source to minimize radiation damage to healthy portions of the body cavity. A device embodying features of the invention can include a sealing member at a location on a shaft of the device proximal to a treatment location therein to seal the passageway leading to the body cavity. Methods for treating a body cavity include methods for delivering a radiation source to a body cavity while minimizing damaging irradiation of healthy tissue.

Claims (34)

1. A method for treating a cavity of a patient's body, comprising:

a.) providing a device having an elongate shaft with a proximal end, a distal end, a treatment location at a distal portion of the shaft and a cavity filling member surrounding the treatment location which has a tissue contacting exterior surface;

b.) providing a radiation shielding component which is configured to control at least in part the emission of radiation emitted from a radiation source within the treatment location;

c.) inserting the device into the patient's body and advancing the device through a passageway therein until the cavity filling member is disposed within the cavity;

d.) applying a vacuum within the cavity to conform tissue surrounding the cavity to the tissue contacting exterior surface of the cavity filling member;

e.) positioning advancing the radiation source through the elongated shaft until the source is disposed within the treatment location; and

f.) adjusting the position of the radiation shielding component within the treatment location to shield portions of the tissue surrounding the cavity from radiation emitted from the radiation source.

2. A method of treating a cavity of a patient's body comprising:

a.) providing a device having an elongate shaft with a proximal end, a distal end, a treatment location at a distal portion of the shaft, a cavity filling member having a tissue contacting outer surface and surrounding the treatment location and a sealing member on the elongated shaft proximal to the cavity filling member;

b.) providing a source for a treatment agent configured to be disposed;

c.) inserting the device into the patient's body and advancing the device through a passageway therein until the cavity filling member is disposed within the cavity and the sealing member is disposed within the passageway;

d.) applying a vacuum within the cavity to conform tissue surrounding the cavity to the tissue contacting exterior surface of the cavity filling member;

e.) sealing the passageway leading to the cavity with the sealing member disposed within the passageway; and

f.) advancing a treatment agent to the treatment location to treat tissue surrounding the cavity.

3. The method of claim 2 wherein the sealing member is expanded to seal the passageway.

4. The method of claim 2 wherein the sealing member is inflatable and inflation fluid is injected into the sealing member to expand the sealing member.

5. The method of claim 2 wherein the treatment agent is a radiation source.

6. The method of claim 5 wherein the radiation source is a brachytherapy seed.

7. The method of claim 5 wherein the radiation source is selected from the group consisting of a liquid containing a radioactive iodine isotope, a slurry of solid isotope, a gel containing a radioactive isotope solid, or a microminiature x-ray tube.

8. The method of claim 2 wherein the sealing member within the passageway maintains a vacuum within the cavity for an effective length of time.

9. The method of claim 1 wherein the cavity filling member is inflated to partially fill the cavity and a vacuum is applied to the cavity to conform tissue surrounding the cavity to the tissue contacting surface of the inflated cavity filling member.

10. The method of claim 1 wherein the device has at least one vacuum port proximal or distal to the cavity filling member and a vacuum is formed in the cavity through the vacuum port in the device.

11. The method of claim 1 wherein the radiation shielding component is slidably disposed within a lumen in the elongate shaft.

12. The method of claim 1 wherein the radiation shielding component is deployed proximal to a radiation source in the treatment location.

13. The method of claim 1 wherein the radiation shielding component is deployed distal to a radiation source in the treatment location.

14. The method of claim 1 wherein the radiation source is a solid material.

15. The method of claim 14 wherein the radiation source is a brachytherapy seed.

16. The method of claim 1 wherein the radiation source is selected from the group consisting of a liquid containing a radioactive iodine isotope, a slurry of solid isotope, a gel containing a radioactive isotope solid, or a microminiature x-ray tube.

17. The method of claim 1 wherein the radiation shielding component is slidably advanced within the elongate shaft until it is deployed in the treatment location.

18. The method of claim 17 wherein the radiation shielding component defines in part a window.

19. The method of claim 18 wherein the length of the window is about 2 millimeters to about 5 centimeters.

20. The method of claim 18 wherein the radiation shielding component has an arcuate shielded area with an angular range between about 20° to about 240°.

21. The method of claim 1 wherein the radiation shielding component has a first portion configured to be deployed distal to the radiation source in the treatment location and a second portion configured to be deployed proximal to the radiation source in the treatment location.

22. The method of claim 21 wherein spacing between the first and second portion of the radiation shield component are adjusted.

Assignments (5)
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE R/F 030755 0031 Recorded Jul 17, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 036127/0538 →
SECURITY AGREEMENT Recorded Jul 9, 2013
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE, INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 030755/0031 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2013
From: SENORX, INC.
To: HOLOGIC, INC.
Reel/Frame 030530/0229 →